AAPS Workshop to Focus on Special Dosage Forms, Developments in In Vitro Drug Release
WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide.
Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.
WHAT: AAPS is pleased to present the workshop on Special Dosage Forms – What’s New with In Vitro Drug Release? This event will present drug release methodologies to evaluate the product performance for special dosage forms and provide opportunities for the participants to interact with the faculty in panel discussions.
WHY: The purpose of this workshop is to engage scientists working in academia, industry, and regulatory agencies in a discussion of special dosage forms such as, buccal, topical, ophthalmic, inhalation, stent, and nanoparticles and in vitro release methodology to test the key performance of the formulation.
WHEN/WHERE: November 7-8, 2009
Los Angeles Convention Center
Los Angeles, CA
CONTACT: For additional information about the workshop visit www.aapspharmaceutica.com/specialdosageforms. To set up an interview with a workshop speaker and to register as press please contact Joe Catapano at 703-248-4772 or CatapanoJ@aaps.org.
Joe Catapano | Newswise Science News
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
New success for Konstanz physicists in studying the quantum vacuum
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...